ERAS
ErascaFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
10
U.S. public peers
Grade Position
Below peers
vs peer average
ERAS vs peer average
15/100
ERAS vs. peer average (F vs. B)
Grade spread
A 2 · B 6 · C 1
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
IOVA is the first available peer comparator.
Useful small-cap oncology comparator for binary clinical sentiment and financing sensitivity, though it is not a mechanism match and should be treated as a loose risk-appetite peer.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
ERAS
Erasca
IOVA
Iovance Biotherapeutics
Grade
F
B
Momentum
28
83
Value
41
41
Sentiment
13
55
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Constructive
Grade position vs IOVA
ERAS / IOVA
Grade Position
Below peers
ERAS vs. peer average (F vs. B)
15/100
Momentum
28
IOVAValue
41
ERASSentiment
13
IOVARotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs ERAS
IOVA is the first peer returned for this comparison set.